... WhatsApp

A New Way to Fight Drug-Resistant Ovarian Cancer

You are here >> Home > Latest Updates > Uro & Gynec > HIPEC > A New…

Core-shell hydrogel microspheres with sequential drug release and magnetothermal synergy for drug-resistant ovarian cancer.DOI 10.1039d5bm01191d

Ovarian cancer is often hard to treat. Many women respond well at first. Over time, the cancer can return and stop responding to standard chemotherapy. This is called drug resistance. Once this happens, treatment options become limited.

Researchers are working on smarter ways to deliver cancer drugs. This study explored a new technology designed to tackle drug resistance step by step. The goal is to weaken cancer cells first and then destroy them more effectively.

The scientists created tiny gel-based spheres that carry two treatments inside one package. These spheres are small enough to interact closely with cancer cells. Each layer has a specific job. The outer layer releases a drug that blocks signals used by cancer cells to resist treatment. This release happens quickly, within the first few hours. It prepares the cancer cells to become more sensitive.

After that, the inner core releases a common chemotherapy drug over a longer time. This second step focuses on killing the cancer cells once their defenses are lowered. This timing is important. It allows treatment to work in a planned sequence rather than all at once.

The spheres also contain magnetic particles. When exposed to a special magnetic field, they gently heat up. This heat helps damage cancer cells and boosts the effect of chemotherapy. The temperature stays in a safe range that targets tumor cells without harming surrounding tissue.

In lab studies, this combined approach worked better than chemotherapy or heat alone. Cancer cell survival dropped sharply within two days. This shows strong potential against ovarian cancer cells that no longer respond to standard drugs.

This method may offer a less invasive option compared to heated chemotherapy given during surgery. It is still early research and has only been tested in the laboratory. More studies are needed before it can be used in patients.

The idea is promising. Treat resistance first. Then deliver precise treatment. This approach may lead to better control of ovarian cancer that no longer responds to current therapies.

Rate this post
Robotic Cancer Surgery
Best robotic cancer surgery in Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.